High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.

Untitled work

(2001) · RePEc: Research Papers in Economics · Cited by 27,577

Revisiting the Behavioral Model and Access to Medical Care: Does it Matter?

Andersen, R. M. (1995) · Journal of Health and Social Behavior · doi:10.2307/2137284 · Cited by 9,831

Variable Selection for Propensity Score Models

Brookhart, M. A., Schneeweiss, S., Rothman, K. J., Glynn, R. J., Avorn, J., & Stürmer, T. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj149 · Cited by 2,336

Evaluating medication effects outside of clinical trials: new-user designs

Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646

A review of uses of health care utilization databases for epidemiologic research on therapeutics

Schneeweiß, S., & Avorn, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.012 · Cited by 1,290

Estimation of Causal Effects using Propensity Score Weighting: An Application to Data on Right Heart Catheterization

Hirano, K., & Imbens, G. W. (2001) · Health Services and Outcomes Research Methodology · doi:10.1023/a:1020371312283 · Cited by 1,039

Unified Methods for Censored Longitudinal Data and Causality

van der Laan, M. J., & Robins, J. M. (2003) · Springer series in statistics · doi:10.1007/978-0-387-21700-0 · Cited by 979

Quantifying Biases in Causal Models: Classical Confounding vs Collider-Stratification Bias

Greenland, S. (2003) · Epidemiology · doi:10.1097/01.ede.0000042804.12056.6c · Cited by 810

A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods

Stürmer‎, T., Joshi, M., Glynn, R. J., Avorn, J., Rothman, K. J., & Schneeweiß, S. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.07.004 · Cited by 668

Relationship Between Selective Cyclooxygenase-2 Inhibitors and Acute Myocardial Infarction in Older Adults

Solomon, D. H., Schneeweiß, S., Glynn, R. J., Kiyota, Y., Levin, R., Mogun, H., & Avorn, J. (2004) · Circulation · doi:10.1161/01.cir.0000127578.21885.3e · Cited by 506

Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada

Dubois, C., Fernandes, H. V. J., Lin, M., Martins, K. J. B., Dyck, J. R. B., Klarenbach, S. W., Richer, L. P., Jess, E., Hanlon, J. G., Hyshka, E., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-18356-6 · Cited by 4

A Causal Inference Methodology to Support Research on Osteopenia for Breast Cancer Patients

Kiriakidou, N., Ballas, A., Hernándo, C., Miralles-Marco, A., Stamati, T., Anagnostopoulos, D., & Diou, C. (2024) · Applied Sciences · doi:10.3390/app14219700 · Cited by 4

Evaluating the Role of High‐Dimensional Proxy Data in Confounding Adjustment in Multiple Sclerosis Research: A Case Study

Karim, M. E., Hossain, M. B., Ng, H. S., Zhu, F., Frank, H. A., & Tremlett, H. L. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70112 · Cited by 4

Comparative ranking of marginal confounding impact of natural language processing-derived versus structured features in pharmacoepidemiology

Plasek, J. M., Wyss, R., Weberpals, J. G., Yang, J., DeRamus, T. P., Tsacogianis, T., Ngan, K., Bessette, L. G., Lin, K. J., & Zhou, L. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109855 · Cited by 4

How Effective Are Machine Learning and Doubly Robust Estimators in Incorporating High‐Dimensional Proxies to Reduce Residual Confounding?

Karim, M. E., & Lei, Y. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70155 · Cited by 4

Is there a competitive advantage to using multivariate statistical or machine learning methods over the Bross formula in the hdPS framework for bias and variance estimation?

Karim, M. E., & Lei, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324639 · Cited by 4

Use of Machine Learning to Compare Disease Risk Scores and Propensity Scores Across Complex Confounding Scenarios: A Simulation Study

Guo, Y., Strauss, V. Y., Khalid, S., & Prieto‐Alhambra, D. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70165 · Cited by 4

Paiement à la performance et fixation conditionnelle du prix du médicament

Launois, R., Ghabri, S., Navarrete, L. F., Moine, J.-G. L., & Ethgen, O. (2014) · Revue française des affaires sociales · doi:10.3917/rfas.144.0156 · Cited by 4

Second-Line Intraperitoneal Chemotherapy for Recurrent Epithelial Ovarian, Tubal and Peritoneal Cancer: A Propensity Score-Matching Study

Lu, C., Chang, Y., Lee, W.-H., Chang, Y., Peng, C.-W., Chuang, C.-M., & Task Force on Intraperitoneal Chemotherapy of Ovarian Cancer (2016) · Chemotherapy · doi:10.1159/000443924 · Cited by 4

Hospitalization for musculoskeletal disorders in rheumatoid arthritis patients: a population-based study

Machado, M. A. D. Á., Bernatsky, S., Bessette, L., Nedjar, H., & Rahme, E. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1142-4 · Cited by 4

Selecting and Integrating Data Sources in Benefit–Risk Assessment: Considerations and Future Directions

DiSantostefano, R. L., Berlin, J. A., Chuang‐Stein, C., Quartey, G., Eichenbaum, G. M., & Levitan, B. S. (2016) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2016.1225596 · Cited by 4

La déclaration RECORD-PE (Reporting of Studies Conducted Using Observational Routinely Collected Health Data Statement for Pharmacoepdemiology) : directives pour la communication des études realisées à partir de données de santé observationelles collectées en routine en pharmacoépidémiologie

Langan, S., Schmidt, S. A. J., Wing, K., Ehrenstein, V., Nicholls, S. G., Filion, K. B., Klungel, O. H., Petersen, I., Sørensen, H. T., Dixon, W. G., et al. (2019) · Canadian Medical Association Journal · doi:10.1503/cmaj.190347 · Cited by 4

Secondary prevention of acute coronary syndrome with antiplatelet agents in real life: A high-dimensional propensity score matched cohort study in the French National claims database

Blin, P., Dureau‐Pournin, C., Jové, J., Lassalle, R., Droz‐Perroteau, C., & Moore, N. D. (2020) · MethodsX · doi:10.1016/j.mex.2020.100796 · Cited by 4

Introduction to High-dimensional Propensity Score Analysis

Ishimaru, M. (2020) · Annals of Clinical Epidemiology · doi:10.37737/ace.2.4_85 · Cited by 4

Cost-effectiveness of the adherence with recommendations for clinical monitoring of patients with diabetes

Corrao, G., Rea, F., Mancia, G., Perseghin, G., Merlino, L. G., Martini, N., Carbone, S., Carle, F., Bucci, A., Carle, F., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.07.014 · Cited by 4

Timing of AKI after urgent percutaneous coronary intervention and clinical outcomes: a high-dimensional propensity score analysis

Go, A. S., Tan, T. C., Parikh, R., Ambrosy, A. P., Pravoverov, L. V., Zheng, S., & Leong, T. K. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02513-9 · Cited by 4

Nonbenzodiazepine hypnotics and police-reported motor vehicle crash risk among older adults: a sequential target trial emulation

Zullo, A. R., Khan, M. A., Pfeiffer, M. R., Margolis, S. A., Ott, B. R., Curry, A. E., Bayer, T. A., Riester, M. R., & Joyce, N. R. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae168 · Cited by 4

Estimation of biomarker distributions using laboratory data collected during routine delivery of medical care

Brookhart, M. A., Todd, J., Li, X., Reams, B. D., Pate, V., & Kshirsagar, A. V. (2014) · Annals of Epidemiology · doi:10.1016/j.annepidem.2014.07.013 · Cited by 4

Comparative effectiveness of weekly versus every-2-weeks cetuximab in metastatic colorectal cancer in a US-insured population

Lamy, F.-X., Batech, M., Boutmy, E., Ronga, P., Salim, S., & Pescott, C. P. (2020) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2020-0132 · Cited by 4

A pragmatic methodology for the evaluation of digital care management in the context of multimorbidity

Lindemer, E., Jouni, M., Nikolaev, N., Reidy, P., Mattie, H., Rogers, J. K., Giangreco, L., Sherman, M., Bartels, M., & Panch, T. (2021) · Journal of Medical Economics · doi:10.1080/13696998.2021.1890416 · Cited by 4

The Other Side of Prenatal Depression: Developmental Outcomes Associated with Antidepressant Medication Therapy

Rotem‐Kohavi, N., Goodman, S. H., Wazana, A. D., & Oberlander, T. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-60159-1_19 · Cited by 4

Estimation of the Prevalence of Chronic Kidney Disease in People with Diabetes by Combining Information from Multiple Routine Data Collections

Geroldinger, A., Hronský, M., Endel, F., Endel, G., Oberbauer, R. W., & Heinze, G. (2021) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/rssa.12682 · Cited by 4

Effectiveness and Safety of Direct Oral Anticoagulants Among Octogenarians with Venous Thromboembolism: An International Multidatabase Cohort Study

Douros, A., Basedow, F., Cui, Y. J., Dimakos, J., Walker, J., Enders, D., & Tagalakis, V. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.08.033 · Cited by 4

hdps: A suite of commands for applying high-dimensional propensity-score approaches

Tazare, J., Smeeth, L. L., Evans, S. J. W., Douglas, I., & Williamson, E. (2023) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x231196288 · Cited by 4

The challenges of comparing results between placebo controlled randomized trials and non‐experimental new user, active comparator cohort studies: the example of olmesartan

Castillo, W. C., Delaney, J. A., & Stürmer‎, T. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3602 · Cited by 4

Adherence to statin therapy: the key to survival?

Andersohn, F. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02302.x · Cited by 4

Association of Part D coverage gap with COPD medication adherence.

Yu, Y., Hearld, L. R., Qu, H., Ray, M. N., & Kilgore, M. L. (2016) · PubMed · Cited by 4

Comment mesurer l’efficacité en vie réelle ?

Launois, R., Trouiller, J.-B., & Cabout, E. (2018) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2018.07.003 · Cited by 4

Development and Evaluation of Infrastructure and Analytic Methods for Systematic Drug Safety Surveillance: Lessons and Resources from the Observational Medical Outcomes Partnership

Stang, P., Ryan, P. B., Hartzema, A. G., Madigan, D., Overhage, J. M., Welebob, E. M., Reich, C., & Scarnecchia, T. (2014) · Wiley eBooks · doi:10.1002/9781118820186.ch29 · Cited by 4

Benefits and Risks Associated With Antibiotic Prophylaxis for Thyroid Operations

Squires, S. D., Cisco, R. M., Lin, D. T., Trickey, A. W., Kebebew, E., Gombar, S., Yuan, Y., & Seib, C. D. (2024) · Journal of Surgical Research · doi:10.1016/j.jss.2024.06.046 · Cited by 3

Insights on High-Value Procedures From the ISASS 4-Part Webinar Series on Current and Emerging Techniques in Endoscopic Spine Surgery Based on Surgeon Experience

Lewandrowski, K., Li, Z., Liu, X., Xifeng, Z., Kwon, B., Dowling, Á., Knight, M., de Carvalho, P. S. T., Kim, C. W., Basil, G. W., et al. (2024) · The International Journal of Spine Surgery · doi:10.14444/8676 · Cited by 3

Large-scale Empirical Identification of Candidate Comparators for Pharmacoepidemiological Studies

Bohn, J. M., Gilbert, J. P., Knoll, C., Kern, D. M., & Ryan, P. B. (2025) · Drug Safety · doi:10.1007/s40264-025-01569-y · Cited by 3

Identifying Drugs Associated With Parkinson's Disease Risk Using Machine Learning

Pylkkö, E., Courtois, É., Paakinaho, A., Hartikainen, S. A., Kaasinen, V., Elbaz, A., Thiébaut, A. C. M., Ahmed, I., & Tolppanen, A. (2026) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70192 · Cited by 3

Identifying sequential episodes of pharmacotherapy as a method for assessing treatment failure in comparative effectiveness research

Carney, G., Maclure, M., Bassett, K. L., Taylor, S., & Dormuth, C. R. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4926 · Cited by 3

Adaptability of High Dimensional Propensity Score Procedure in the Transition from ICD-9 to ICD-10 in the US Healthcare System

Sarayani, A., Brown, J. D., Hampp, C., Donahoo, W. T., & Winterstein, A. G. (2023) · Clinical Epidemiology · doi:10.2147/clep.s405165 · Cited by 3

Big data in autism research: Methodological challenges and solutions

Lee, B. K., Schendel, D., & Shea, L. (2023) · Autism Research · doi:10.1002/aur.3007 · Cited by 4

Multiply robust causal inference of the restricted mean survival time difference

Shu, D., Mukhopadhyay, S., Uno, H., Gerber, J. S., & Schaubel, D. E. (2023) · Statistical Methods in Medical Research · doi:10.1177/09622802231211009 · Cited by 3

Associations Between Postdischarge Care and Cognitive Impairment–Related Hospital Readmissions for Ketoacidosis and Severe Hypoglycemia in Adults With Diabetes

Wang, Y., Jiao, T., Muschett, M. R., Brown, J. D., Guo, J. S., Kulshreshtha, A., Zhang, Y., Winterstein, A. G., & Shao, H. (2023) · Diabetes Care · doi:10.2337/dca23-0013 · Cited by 3

The Methodological Quality of Observational Studies Examining the Risk of Pregnancy Drug Use on Congenital Malformations Needs Substantial Improvement: A Cross-Sectional Survey

Jia, Y., Wang, J., Liu, C., Zhao, P., Ren, Y. Q., Xiong, Y., Li, G., Chen, M., Sun, X., & Tan, J. (2024) · Drug Safety · doi:10.1007/s40264-024-01465-x · Cited by 3

Accurate treatment effect estimation using inverse probability of treatment weighting with deep learning

Lee, J., Ma, S., Serban, N., & Yang, S. (2025) · JAMIA Open · doi:10.1093/jamiaopen/ooaf032 · Cited by 3

Enhancing risk prediction base on health administrative data using high-dimensional prediction model

Hossain, M. B., Sadatsafavi, M., Wong, H., Cook, V. J., Johnston, J. C., & Karim, M. E. (2025) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2025.111857 · Cited by 3

A novel high dimensional approach to assess heterogeneous treatment effect in claims data

Wang, T., Pate, V., Wyss, R., Buse, J. B., Kosorok, M. R., & Stürmer‎, T. (2025) · American Journal of Epidemiology · doi:10.1093/aje/kwaf127 · Cited by 3

Natural language processing for scalable feature engineering and ultra-high-dimensional confounding adjustment in healthcare database studies

Wyss, R., Yang, J., Schneeweiß, S., Plasek, J. M., Zhou, L., DeRamus, T. P., Weberpals, J. G., Ngan, K., Tsacogianis, T., & Lin, K. J. (2025) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2025.104882 · Cited by 3

Heart transplant outcomes in patients with substance use disorder history: a nationwide cohort study using high-dimensional propensity score matching

Elkrief, K., Lavín, P., Greenway, K. T., Tate, S., Hussain, F., Pike, C. W., Trépanier, A., Hui, G., Lespérance, P., Kudrina, I., et al. (2025) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaf117 · Cited by 3

Sequential Value-of-Information Assessment for Prospective Drug Safety Monitoring Using Claims Databases

Patrick, A. R., Franklin, J. M., Weinstein, M. C., Glynn, R. J., & Schneeweiß, S. (2013) · Medical Decision Making · doi:10.1177/0272989x13497997 · Cited by 3

Conducting Privacy-Preserving Multivariable Propensity Score Analysis When Patient Covariate Information Is Stored in Separate Locations

Bohn, J. M., Eddings, W., & Schneeweiß, S. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kww155 · Cited by 3

Safety of psychotropic medicines: contribution from observational evidence

Verdoux, H. (2018) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796018000276 · Cited by 3

Thiazolidinediones and reduced risk of incident bacterial abscess in adults with type 2 diabetes: A population‐based cohort study

Wang, J., Dong, Y., Ko, W., Chang, C., Wu, L., Chuang, L., & Chen, P. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13461 · Cited by 3

Influenza immunization during pregnancy: toward a balanced assessment of safety evidence

Fell, D. B., Omer, S. B., & Edwards, K. M. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1599679 · Cited by 3

Real-World Trends in the Evaluation of Medical Products

Hennessy, S., & Berlin, J. A. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac172 · Cited by 3

Epidemiological surveillance of drug safety using cumulative sequential analysis in electronic healthcare data

Aakjær, M., Bruin, M. D. D., & Andersen, M. (2023) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13955 · Cited by 3

A methodological review of the high-dimensional propensity score in comparative-effectiveness and safety-of-interventions research finds incomplete reporting relative to algorithm development and robustness

Martin, G. L., Petri, C. F., Rozenberg, J., Simon‐Tillaux, N., Hajage, D., Kirchgesner, J., Tubach, F., Létinier, L., & Dechartres, A. (2024) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2024.111305 · Cited by 3

The COVID-19 Pandemic Was Associated with a Change in Therapeutic Management and Mortality in Heart Failure Patients

Ponzoni, M., Morabito, G., Corrao, G., Gerosa, G., Cantarutti, A., & Rea, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092625 · Cited by 3

Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care Data

Kim, D. H., Park, C. M., Ko, D., Lin, K. J., & Glynn, R. J. (2024) · Drugs & Aging · doi:10.1007/s40266-024-01121-0 · Cited by 3

Accelerating adverse pregnancy outcomes research amidst rising medication use: parallel retrospective cohort analyses for signal prioritization

Hwang, Y. M., Piekos, S. N., Paquette, A. G., Wei, Q., Price, N. D., Hood, L., & Hadlock, J. (2024) · BMC Medicine · doi:10.1186/s12916-024-03717-0 · Cited by 3

Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population‐based cohort study

Antoniou, T., Yao, Z., Camacho, X., Mamdani, M., Juurlink, D. N., & Gomes, T. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3761 · Cited by 3

Informatics for Nutritional Genetics and Genomics

Gao, Y., & Chen, J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5717-5_7 · Cited by 4

Predicting Patients' Readmission

Zanovello, S., Donisi, V., Tedeschi, F., Ruggeri, M., Moretti, F., Rimondini, M., & Amaddeo, F. (2020) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001140 · Cited by 3

Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study

Bidulka, P., Iwagami, M., Mansfield, K. E., Kalogirou, F., Wong, A. Y. S., Douglas, I., Smeeth, L. L., Summers, C., & Tomlinson, L. A. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15873.1 · Cited by 3

Why Machine Learning Cannot Ignore Maximum Likelihood Estimation

van der Laan, M. J., & Rose, S. (2023) · Chapman & Hall/CRC eBooks · doi:10.1201/9781003102670-22 · Cited by 3

Robust causal inference of drug‐drug interactions

Shu, D., Han, P., Hennessy, S., & Miano, T. A. (2023) · Statistics in Medicine · doi:10.1002/sim.9653 · Cited by 3

Safety of prenatal opioid analgesics: Do results differ between public health insurance beneficiary and population‐based cohorts?

Brogly, S. B., Bowie, A. C., Li, W., Camden, A., Vélez, M. P., Guttmann, A., & Werler, M. M. (2023) · Birth Defects Research · doi:10.1002/bdr2.2147 · Cited by 3

Effects of Antidepressants on COVID-19 Outcomes: Retrospective Study on Large-Scale Electronic Health Record Data

Rahman, M. M., Mahi, A. M., Melamed, R., & Alam, M. A. U. (2023) · Interactive Journal of Medical Research · doi:10.2196/39455 · Cited by 3

Protocols for Observational Studies: Methods and Open Problems

Small, D. S. (2024) · Statistical Science · doi:10.1214/24-sts945 · Cited by 4

Evaluating Methods for Intersectoral Comparison of Quality of Care

Ohlmeier, C., Linder, R., Enders, D., Mikolajczyk, R., Haverkamp, W., Horenkamp‐Sonntag, D., & Garbe, E. (2014) · Methods of Information in Medicine · doi:10.3414/me13-01-0132 · Cited by 3

Design and analysis of post-marketing research

Zhou, X., & Yang, W. (2013) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-013-1501-z · Cited by 3

The effectiveness of perindopril vs. lisinopril on reducing the incidence of diabetes and renal diseases: A cohort study of 20,252 patients

Wong, M. C. S., Tam, W., Wang, H., Zhang, D., Cheung, C. S. K., Yan, B. P., Leeder, S., & Griffiths, S. M. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.04.191 · Cited by 3

It Is Time to Care About Ventilator-Associated Tracheobronchitis*

Muszynski, J. A., Steward, S., & Brilli, R. J. (2015) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000417 · Cited by 3

Study protocol for the dabigatran, apixaban, rivaroxaban, edoxaban, warfarin comparative effectiveness research study

Krumme, A. A., Pawar, A. M., Schneeweiß, S., Glynn, R. J., Choudhry, N. K., Kulldorff, M., Ortiz, A. S., Avorn, J., & Gagne, J. J. (2017) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2017-0053 · Cited by 3

Controlling Confounding in a Study of Oral Anticoagulants: Comparing Disease Risk Scores Developed Using Different Follow-Up Approaches

Bohn, J. M., Schneeweiß, S., Glynn, R. J., Toh, S., Wyss, R., Desai, R. J., & Gagne, J. J. (2019) · eGEMs (Generating Evidence & Methods to improve patient outcomes) · doi:10.5334/egems.254 · Cited by 3

Survival after Anticancer Treatment of Terminally Ill Patients with Ovarian Carcinoma

Kajiyama, H., Suzuki, S., Shimbo, A., Utsumi, F., Yoshikawa, N., & Kikkawa, F. (2020) · Journal of Palliative Medicine · doi:10.1089/jpm.2019.0456 · Cited by 3

Economic Burden of Central Nervous System Metastases in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Schwartz, N. R. M., DeBusk, K. P. A., Forero, A., Feliciano, J., Anupindi, V. R., Yeaw, J., & McBride, A. (2021) · Future Oncology · doi:10.2217/fon-2020-1292 · Cited by 3

Drug repurposing of dextromethorphan as a cellular target for the management of influenza

Cummings, T. H., Magagnoli, J., Hardin, J. W., & Sutton, S. S. (2021) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2618 · Cited by 3

Incidence of Acute Renal Failure in Patients Using Levetiracetam Versus Other Antiseizure Medications: A Voluntary Post-Authorization Safety Study

Beau‐Lejdstrom, R., Hong, L. S., García‐Albéniz, X., Floricel, F., Lorenzen, J. M., Bonfitto, F., Kalilani, L., Loesch, C., Luscombe, G. P., Perez‐Gutthann, S., et al. (2022) · Drug Safety · doi:10.1007/s40264-022-01193-0 · Cited by 3

Score de propension : intérêts, utilisation et limites. Un guide pratique pour le clinicien

Moulis, G., & Lapeyre‐Mestre, M. (2018) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2018.02.012 · Cited by 3

Improving Propensity Score Methods in Pharmacoepidemiology

Ali, M. S. (2014) · Utrecht University Repository (Utrecht University) · Cited by 3

Collaborative targeted inference from continuously indexed nuisance parameter estimatorsPreprint

Ju, C., Chambaz, A., & van der Laan, M. J. (2018) · arXiv (Cornell University) · doi:10.48550/arxiv.1804.00102 · Cited by 3

Variable Selection and Adjustment in Relation to Propensity Scores and Prognostic Scores: From Single-level to Multilevel Data

Yu, B. (2012) · Library and Archives Canada (Government of Canada) · Cited by 3

Pirfenidone in idiopathic pulmonary fibrosis: hitting two birds with one stone?

Montesi, S. B., & Khor, Y. H. (2025) · European Respiratory Journal · doi:10.1183/13993003.02224-2024 · Cited by 3

Utility of automated data-adaptive propensity score method for confounding by indication in comparative effectiveness study in real world Medicare and registry data

Kumamaru, H., Jalbert, J. J., Nguyen, L. L., Williams, L. A., Miyata, H., & Setoguchi, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272975 · Cited by 2

Exact-matching algorithms using administrative health claims database equivalence factors for real-world data analysis based on the target trial emulation framework

Nishioka, Y., Morita, E., Takeshita, S., Tamamoto, S., Myojin, T., Noda, T., & Imamura, T. (2024) · Health Services and Outcomes Research Methodology · doi:10.1007/s10742-024-00322-9 · Cited by 2

Economic burden of recurrent hyperkalemia in patients with chronic kidney disease

Bakris, G. L., Agiro, A., Greatsinger, A., Mu, F., Cook, E. E., Sundar, M., Louden, E. M., Colman, E., & Desai, P. (2024) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2024.24114 · Cited by 2

Comparative effectiveness and safety of escalating to triple therapy versus switching to dual bronchodilators after discontinuing LABA/ICS in patients with COPD: a retrospective cohort study

Wu, L., Lin, T., Lin, T., Liou, Y., Tsai, C., Yang, K., & Wang, M. (2024) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666241292242 · Cited by 2

Outcome adaptive propensity score methods for handling censoring and high-dimensionality: Application to insurance claims

Du, J., Yu, Y., Zhang, M., Wu, Z., Ryan, A. M., & Mukherjee, B. (2025) · Statistical Methods in Medical Research · doi:10.1177/09622802241306856 · Cited by 2

Association of a Veterans Affairs Toxic Exposure Medical Evaluation with Symptom-Related Care

Almekdash, M. H., Han, J., Guffey, D., Christie, I. C., Helmer, D. A., & Wu, T. D. (2025) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202408-835oc · Cited by 2

The impact of bias due to exponentiation in the estimation of hazard, risk, and odds ratios: an empirical investigation from 1,495,059 effect sizes from MEDLINE/PubMed abstracts

Košuta, T., Heinze, G., Kastrin, A., Kosmidis, I., & Blagus, R. (2025) · BMC Medical Research Methodology · doi:10.1186/s12874-025-02573-7 · Cited by 2

High‐Dimensional Disease Risk Score for Dealing With Residual Confounding Bias in Estimating Treatment Effects With a Survival Outcome

Hossain, M. B., Wong, H., Sadatsafavi, M., Cook, V. J., Johnston, J. C., & Karim, M. E. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70172 · Cited by 2

Evaluation of the impact of defining observable time in real-world data on outcome incidence

Blacketer, C., Defalco, F., Conover, M. M., Ryan, P. B., Schuemie, M., & Rijnbeek, P. (2025) · J. Am. Medical Informatics Assoc. · doi:10.1093/jamia/ocaf119 · Cited by 2

Comparison of the rates of emergent otologic adverse events following mRNA COVID-19 versus influenza vaccination: a matched cohort analysis

Munjal, T., Batts, S. A., Gombar, S., & Stanković, K. M. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1637870 · Cited by 2

Comparison of readmission outcomes and complications between leadless and traditional transvenous pacemakers in older adults: a nationwide readmission analysis of 49852 admission events

He, J., Liang, K., Huang, R., Su, C., Zhou, J.-C., Wang, L., & Zhou, J. (2025) · EP Europace · doi:10.1093/europace/euaf268 · Cited by 2

Comparative effectiveness and safety of fluticasone-based versus beclometasone-based single-inhaler triple therapies in patients with chronic obstructive pulmonary disease: a population-based cohort study

Dong, Y., Pan, S., Chen, M.-C., Chen, C., Tsai, N.-H., & Kumamaru, H. (2025) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-025-02037-4 · Cited by 2

Telemedicine visits for new onychomycosis diagnoses result in fewer antifungal prescriptions than in-person care: A retrospective cohort study

Gupta, S. V., Chen, K., Tang, C., Pike, C. W., Hui, G., Coyle, J., & Rana, J. (2025) · JAAD International · doi:10.1016/j.jdin.2025.11.019 · Cited by 2

Estrogen exposure from modern contraceptives and vascular risk in women with migraine: A nationwide electronic medical record database study

Ihara, K., Pike, C. W., Hui, G., Gombar, S., Jackson, M. L., Callahan, A., Tietjen, G. E., & Chiang, C. (2025) · Cephalalgia · doi:10.1177/03331024251404924 · Cited by 2

A missed opportunity: a retrospective cohort study of alcohol use disorder pharmacotherapy in hospitalized patients

Nazon, M., Lavín, P., Pike, C. W., Greenway, K. T., Richard, J., Lespérance, P., Ostacher, M. J., Jutras‐Aswad, D., Tate, S., Lembke, A., et al. (2026) · Alcohol and Alcoholism · doi:10.1093/alcalc/agag008 · Cited by 2

An operational target trial emulation framework for causal inference using electronic health record data

Wang, Y., Li, Y., Lin, T., & Guo, Y. (2026) · npj Digital Medicine · doi:10.1038/s41746-026-02563-z · Cited by 3

Comparative cost-effectiveness of robot-assisted versus open prostatectomy: a real-life nationwide study

Préaubert, N., Bénard, A., Blin, P., Jové, J., Bladou, F., Piazza, L., & Robert, G. (2026) · Journal of Robotic Surgery · doi:10.1007/s11701-026-03796-6 · Cited by 2

Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced CKD Not Requiring Dialysis

Chen, Q., Singer, D. E., Fu, E. L., Yang, C., Pritchard, K. T., Desai, R. J., & Lin, K. J. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.32225 · Cited by 2

Evaluating the Performance of High-Dimensional Propensity Scores Compared with Standard Propensity Scores for Comparing Antihypertensive Therapies in the CPRD GOLD Database

Simon, V., & Vadel, J. (2023) · Cardiology and Therapy · doi:10.1007/s40119-023-00316-7 · Cited by 2

Is the long-term poor prognosis of acute myocardial infarction in patients with mental illness mediated through their poor adherence with recommended healthcare?

Corrao, G., Compagnoni, M. M., Conflitti, C., & Lora, A. (2024) · European Journal of Public Health · doi:10.1093/eurpub/ckae005 · Cited by 2

Clinical outcomes after transcatheter aortic valve implantation in nonagenarian patients: A retrospective population-based cohort study

Franchi, M., Gennari, M., Severgnini, G., Biancari, F., Bonomi, A., MARCO, F. D., Polvani, G., & Agrifoglio, M. (2025) · Annals of Epidemiology · doi:10.1016/j.annepidem.2025.01.005 · Cited by 2

Evaluation of the Performance of the High-Dimensional Propensity Score Algorithm to Adjust for Confounding of Treatment Effects Estimated in Healthcare Claims Data

Le, H. V. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/9srw-nw85

Confounding adjustment via a semi‐automated high‐dimensional propensity score algorithm: an application to electronic medical records

Toh, S., Rodríguez, L. A. G., & Hernán, M. Á. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2152 · Cited by 85

High dimensional versus conventional propensity score matching investigating gastrointestinal complications in coxib users vs. nonselective NSAIDS users

Garbe, E., Kloss, S., Schill, W., Suling, M., & Schneeweiss, S. (2011) · German Medical Science (German Research Foundation) · doi:10.3205/11gmds243

Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example

Le, H. V., Poole, C., Brookhart, M. A., Schoenbach, V. J., Beach, K. J., Layton, J. B., & Stürmer‎, T. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-142 · Cited by 24

High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications

Garbe, E., Kloss, S., Suling, M., Pigeot, I., & Schneeweiß, S. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1334-2 · Cited by 60